Apart from that, different studies pointed out that many colon tumors possess an increased expression level of GnRH-R [39], therefore a variety of synthetic therapeutics have been used which target these receptors and hence revealed significant tumor growth inhibition in vitro and in vivo [22,24,26,32,34]. Here, GNRHR is linked to colonic neoplasm.